# Risk of tuberculosis reactivation with interleukin (IL)‐17 and IL‐23 inhibitors in psoriasis – time for a paradigm change

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/risk-of-tuberculosis-reactivation-with-interleukin-il-17-and-il-23-inhibitors-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Miguel Nogueira,Richard B. Warren,Tiago Torres |
| Citations | 95 |
| DOI | 10.1111/jdv.16866 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3048991672 |
| PMID | 32790003 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Tiago Torres](https://scholariq.org/researchers/tiago-torres/)

## Paper journal

- [Journal of the European Academy of Dermatology and Venereology](https://scholariq.org/journals/journal-of-the-european-academy-of-dermatology-and-venereology/)

## Paper primary topic

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Paper topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Tuberculosis Research and Epidemiology](https://scholariq.org/topics/tuberculosis-research-and-epidemiology/)
- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.